All eyes on $NVDA Follow the latest updates and analysis ahead of Nvidia's blockbuster report. OTC Markets OTCPK - Delayed Quote • USD Restart Life Sciences Corp. (NMLSD) Follow Add holdings 0.0534 0.0000 (0.00%) As of May 22 at 4:00:00 PM EDT. Market Open. All News Press Releases SEC Filings Restart Life Expands Intellectual Property Through Trademark Licensing Agreement Vancouver, British Columbia--(Newsfile Corp. - March 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to announce that it has secured the licensing rights to health-related trademarks, a strategic move that will play a role in the Company's future brand development initiatives. This agreement aligns with Restart Life's efforts to strengthen its market position and expand its product portfolio.Restart Life has secured . Restart Life Secures Strategic Production Partner Vancouver, British Columbia--(Newsfile Corp. - February 19, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to announce that the Company has secured a strategic production partnership with a Canadian co-packer. This new strategic partnership follows the press release dated December 13, 2024, where Restart Life and Brain Balls Inc. formed a Joint Venture to bring health-focused products to market, targeting cognitive perfo Restart Life Announces Key Business Updates Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Restart Life Science Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to provide an update on recent developments under the leadership of its newly appointed CEO. Steve Loutskou, a serial entrepreneur, is dedicated to driving shareholder value through sustainable growth and expanding opportunities for the Company."I would like to thank our shareholders for their support in our private Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction Vancouver, British Columbia--(Newsfile Corp. - February 7, 2025) - Restart Life Science Corp. (CSE: HEAL) (FSE: HN3) (OTC Pink: NMLSD) ("Restart Life" or the "Company") announces that the Company proposes to enter into debt settlement agreements with certain creditors (the "Creditors") to settle up to CAD$120,000 in debt (the "Debt Settlement").Pursuant to the Debt Settlement, the Company shall issue units (the "Units") at a price of $0.075 per Unit. Each Unit will consist ... Performance Overview Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) Return NMLSD S&P/TSX Composite index (^GSPTSE) YTD +77.97% +6.73% 1-Year -64.41% +18.02% 3-Year -92.09% +26.64%